Variant #0000735154 (NC_000012.11:g.34179599_34179600del, NM_032834.3:c.1171_1172del (ALG10))
Individual ID |
00334880 |
Chromosome |
12 |
Allele |
Both (homozygous) |
Affects function (as reported) |
Effect unknown |
Affects function (by curator) |
Not classified |
Classification method |
ACMG |
Clinical classification |
VUS |
DNA change (genomic) (Relative to hg19 / GRCh37) |
g.34179599_34179600del |
DNA change (hg38) |
g.34026664_34026665del |
Published as |
1170_1171delAA |
ISCN |
- |
DB-ID |
ALG10_000001 |
Variant remarks |
ACMG PM2, PM3, PP4; There are no previous reports of neurological disease associated with ALG10 pathogenic variants. However, the novel homozygous frameshift variant is consistent with the confirmation that the parents are related. Functional studies support the damaging in silico prediction for the variant and the gene is biologically highly plausible as a member of the same glycosylation pathway as NUS1 and DHDDS. In the absence of a second unrelated patient with a variant in this gene, we remain cautious and report the variant as pathogenic and ALG10 as a new PME gene with moderate confidence. |
Reference |
PubMed: Courage 2021, Journal: Courage 2021 |
ClinVar ID |
- |
dbSNP ID |
- |
Origin |
Germline |
Segregation |
yes |
Frequency |
- |
Re-site |
- |
VIP |
- |
Methylation |
- |
Average frequency (gnomAD v.2.1.1) |
Retrieve |
Owner |
Carolina Courage |
Database submission license |
No license selected |
Created by |
Carolina Courage |
Date created |
2021-03-02 09:57:11 +01:00 (CET) |
Date last edited |
2021-04-14 10:21:27 +02:00 (CEST) |

Variant on transcripts
Screenings
|